DEC 19, 2017 5:10 PM PST

Human Genetic Variability Impacts the Efficacy of Medicine

WRITTEN BY: Carmen Leitch

The genetic material we carry in our cells is unique to us, and the field of personalized medicine studies how those individual differences affect our health, and the therapeutics that we use. Now, scientists from the University of Copenhagen and the MRC Laboratory of Molecular Biology in Cambridge have assessed the genetic differences between individuals in an important class of receptors, GPCRs. Drugs frequently target those receptors, and they wanted to know how drug efficacy may change depending on changes in the GPCR gene. Their work was reported in Cell.

A small number of people carry mutations in the GPCR gene that don't cause problems, but probably render medications ineffective. / Image credit: Pixabay

“We estimate that an average of three percent of the population have receptors that contain mutations which can alter the effect of medicine,” noted the first author of the study, Alexander Hauser, a postdoctoral fellow at the Department of Drug Design and Pharmacology at the University of Copenhagen. 

People that carry these mutations still have functional receptors, but the mutations have a varying effect on how well drugs work. “This might mean that the medicine simply works less efficiently. It can also mean that the medicine does not work at all or causes adverse effects on patients,” explained the senior author of the work, Madan Babu, from the MRC Lab of Molecular Biology in Cambridge.

For this research, the investigators utilized whole genome sequencing to assess mutations in human GPCRs. They used data from about 2,500 individuals included in the 1,000 Genomes project, in addition to exome data, assessing the portions of the genome that are transcribed into RNA, from 60,000 participants of the ExAC project. Structural data was then employed to reveal the mutations that were most likely to change how medicine would work.

“The three percent of the affected population is an average. For some important receptors, it is way more. For instance, the relevant mutations occur in 69 percent of people in the GLP1 receptor that is the target of diabetes medicine and in 86 percent of people in the CNR2 receptor that is used as a target for medicine to relieve nausea induced by chemotherapy. But of course, we cannot know every person's genome and so these are estimates based on the data sets available,” said Hauser.

The researchers used their data to find out how many people were spending money on drugs that probably were not having any effect. In the UK, it resulted in an economic burden of at least 14 million pounds, or around 19 million dollars annually, when taking people with mutations in important places in both copies of their GPCR gene into account.

“The prevalence and potential impact of variation in drug response between individuals is a strong argument for further researching this field. It also constitutes a fine example of why personalized medicine might be the way forward; even when we are talking about common drugs,” said Hauser.

Learn more about how genetics can be used to tailor therapies to the individual in this video about pharmacogenomics, from Mayo Clinic.


Sources: AAAS/Eurekalert! Via University of Copenhagen, Cell

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 01, 2020
Microbiology
The Most Common Marine Microbe Has a Virus in Its Genome
JUN 01, 2020
The Most Common Marine Microbe Has a Virus in Its Genome
Single-celled ocean microbes known as Pelagibacter or SAR11 make up about 25 percent of the plankton on the planet.
JUN 14, 2020
Chemistry & Physics
Why Are There So Few Black People in STEM?
JUN 14, 2020
Why Are There So Few Black People in STEM?
On June 10th, 2020, thousands of STEM scientists and organizations around the world went on strike to protest systemic r ...
JUL 03, 2020
Genetics & Genomics
Why Can Old Mothers Keep Producing Offspring?
JUL 03, 2020
Why Can Old Mothers Keep Producing Offspring?
The children of older mothers tend to have fewer children and have higher mortality. So why is it still biologically pos ...
JUL 13, 2020
Genetics & Genomics
New Therapeutic Targets For Lupus Are Identified
JUL 13, 2020
New Therapeutic Targets For Lupus Are Identified
Advances in computational and genetic technologies have enabled scientists to search the genome to look for places where ...
JUL 18, 2020
Genetics & Genomics
Our Aging Rate May Be Linked to Blood Iron Levels
JUL 18, 2020
Our Aging Rate May Be Linked to Blood Iron Levels
We all know people that look young for their age, while some people seem to age faster than others.
AUG 02, 2020
Genetics & Genomics
In a First, Researchers Edit Cephalopod Genes
AUG 02, 2020
In a First, Researchers Edit Cephalopod Genes
Using the CRISPR-Cas9 gene-editing tool, researchers have knocked out a gene in a cephalopod for the first time.
Loading Comments...